Samsung Bioepis

E850006

Samsung Bioepis is a South Korean biopharmaceutical company specializing in the development and commercialization of biosimilar medicines.

All labels observed (1)

Label Occurrences
Samsung Bioepis canonical 2

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf biopharmaceutical company ⓘ
biosimilar manufacturer ⓘ
businessModel commercialization of biosimilars ⓘ
development of biosimilars ⓘ
collaboratesWith Biogen ⓘ
Biogen Idec ⓘ
linked to: Biogen

Merck & Co. ⓘ
Organon ⓘ
country South Korea ⓘ
focusesOn diabetes ⓘ
immunology ⓘ
oncology ⓘ
ophthalmology ⓘ
followsRegulatoryGuidelinesOf European Medicines Agency ⓘ
U.S. Food and Drug Administration ⓘ
foundedAsJointVentureWith Biogen ⓘ
hasOfficialWebsite https://www.samsungbioepis.com ⓘ
hasProduct Amelivu ⓘ
Aybintio ⓘ
Benepali ⓘ
Flixabi ⓘ
Hadlima ⓘ
Imraldi ⓘ
Ontruzant ⓘ
Renflexis ⓘ
hasProductType adalimumab biosimilar ⓘ
bevacizumab biosimilar ⓘ
etanercept biosimilar ⓘ
infliximab biosimilar ⓘ
insulin glargine biosimilar ⓘ
trastuzumab biosimilar ⓘ
hasResearchAndDevelopmentCenterIn Incheon ⓘ
headquartersLocation Incheon ⓘ
Songdo International Business District ⓘ
industry biopharmaceutical ⓘ
biotechnology ⓘ
pharmaceutical ⓘ
languageOfName Korean ⓘ
parentOrganization Samsung Biologics ⓘ
Samsung Group ⓘ
partOf Samsung Life Science business ⓘ
regulatoryApprovalIn Australia ⓘ
Canada ⓘ
European Union ⓘ
South Korea ⓘ
United States ⓘ
specializesIn biologic medicines ⓘ
biosimilars ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Renflexis → isManufacturedBy → Samsung Bioepis ⓘ
Samsung Group → hasSubsidiary → Samsung Bioepis ⓘ